ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

Treat to Target: Rheumatoid Arthritis in Pregnant Patients

Eliza F. Chakravarty, MD, MS  |  October 1, 2012

A treat-to-target approach to managing rheumatoid arthritis can work even in pregnant women

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiologicsdrugMethotrexatepatient carepregnancyRheumatoid arthritis

EULAR: Identify Arthritis Early, Treat it Effectively

Thomas R. Collins  |  October 1, 2012

Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis

Filed under:ConditionsEULAR/OtherMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:EULARInternationalJuvenile idiopathic arthritispatient carePediatricsResearchRheumatoid arthritisrheumatologist

Maintenance of Remission in ANCA-Associated Vasculitis

Paul A. Monach, MD, PhD  |  September 5, 2012

Relapses are common, but difficult to predict and prevent.

Filed under:ConditionsResearch RheumVasculitis Tagged with:ANCA-Associated VasculitisdrugGlucocorticoidsgranulomatosis with polyangiitisMethotrexatepatient careResearchrheumatologistrituximabVasculitis

Coding Corner Question: September’s Coding Challenge

Staff  |  September 5, 2012

How the case is coded.

Filed under:Billing/CodingConditionsPractice SupportRheumatoid Arthritis Tagged with:anti-inflammatoryBillingCodingMethotrexatePractice ManagementRheumatoid arthritisrheumatologist

EULAR 2012: Remission the New Normal for Rheumatoid Arthritis

Thomas R. Collins  |  August 8, 2012

Advances in the rheumatology clinic are promising, two experts say.

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug UpdatesEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:BiologicsEULARHYDROXYCHLOROQUINEinfliximabInternationalMethotrexatepatient careRheumatoid arthritisrheumatologisttocilizumab

Coding Corner Question: August Coding Challenge

Staff  |  August 8, 2012

A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion.

Filed under:Billing/CodingConditionsPractice SupportRheumatoid Arthritis Tagged with:anti-inflammatoryBillingCodingdrugimaginginfliximabPractice ManagementRheumatoid arthritisrheumatologist

Drug Updates: EULAR 2012

Michele B. Kaufman, PharmD, BCGP  |  August 8, 2012

Tracking the results of drug safety and efficacy

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsPsoriatic Arthritis Tagged with:BiologicsdrugEULARimagingInternationalMethotrexatepsoriatic arthritisradiographRheumatoid arthritisrheumatologist

Letter: No European Consensus on Steroid Use in Rheumatoid Arthritis

Tore Saxne, MD, PhD  |  August 8, 2012

There is not a consensus between all European rheumatologists regarding the use of steroids in RA; quite a few share your skepticism, including myself.

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:ClinicaldrugInternationalpatient careRheumatoid arthritisrheumatologistSteroid

Letter: Skepticism on Steroids in RA

Staff  |  July 24, 2012

There is not a consensus between all European rheumatologists regarding the use of steroids in RA; quite a few share your skepticism.

Filed under:Uncategorized Tagged with:RARheumatoid arthritisSteroids

Inflammatory Myopathies in Children

Angela Byun Robinson, MD, and Ann M. Reed, MD  |  July 10, 2012

Treatment options and recent research for juvenile dermatomyositis.

Filed under:ConditionsOther Rheumatic Conditions Tagged with:ANA titerdrugHYDROXYCHLOROQUINEinflammationinflammatory myopathyintravenous immune globulinjuvenile dermatomyositisMethotrexatepatient carePediatricsrheumatologistrituximab

  • « Previous Page
  • 1
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • …
  • 107
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences